Infosys Limited vs Novartis AG — how do they compare? Infosys Limited trades at $12.42 (market cap $50.55B), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 5.8× Infosys Limited's market cap, and Infosys Limited pays the higher dividend (4.16%). Which is the better fit depends on your goals.
| INFY | NVS | |
|---|---|---|
Market Cap | $50.55B | $295.37B |
Sector | Technology | Health |
52-Week High | $20.22 | $168.62 |
52-Week Low | $10.49 | $119.31 |
Enterprise Value | $48.30B | $336.69B |
Dividend Yield | 4.16% | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →